Revance Therapeutics (RVNC)
3.0900 +0.0500 (1.64%)
Revance Therapeutics is a biotechnology company focused on developing innovative therapies for various medical conditions, primarily in the fields of aesthetics, neuromodulation, and pain management. The company specializes in creating advanced drug formulations and delivery technologies that aim to provide longer-lasting effects and improve patient outcomes. Through its proprietary products, Revance aims to address unmet medical needs while enhancing the quality of life for patients. The company's portfolio includes both aesthetic treatments and therapeutic applications, showcasing its commitment to innovation in the healthcare sector.
| Date | Open | High | Low | Close | Volume | Adjusted Close |
|---|---|---|---|---|---|---|
| 12/12/2024 | 3.09 | 3.10 | 3.07 | 3.09 | 6,674,994 | 3.09 |
| 12/11/2024 | 3.02 | 3.04 | 3.02 | 3.04 | 2,737,654 | 3.04 |
| 12/10/2024 | 3.03 | 3.03 | 3.02 | 3.02 | 3,698,271 | 3.02 |
| 12/09/2024 | 3.04 | 3.05 | 3.01 | 3.03 | 22,724,947 | 3.03 |
| 12/06/2024 | 3.88 | 3.95 | 3.77 | 3.82 | 1,150,762 | 3.82 |
| 12/05/2024 | 4.06 | 4.14 | 3.74 | 3.94 | 1,220,825 | 3.94 |
| 12/04/2024 | 3.86 | 4.17 | 3.84 | 4.17 | 1,979,874 | 4.17 |
| 12/03/2024 | 3.90 | 4.12 | 3.73 | 3.92 | 1,554,353 | 3.92 |
| 12/02/2024 | 3.61 | 3.75 | 3.55 | 3.73 | 1,203,598 | 3.73 |
| 11/29/2024 | 3.67 | 3.84 | 3.61 | 3.61 | 1,896,957 | 3.61 |
| 11/27/2024 | 4.03 | 4.21 | 3.77 | 3.78 | 2,407,242 | 3.78 |
| 11/26/2024 | 3.97 | 4.20 | 3.87 | 4.02 | 2,175,164 | 4.02 |
| 11/25/2024 | 3.70 | 3.82 | 3.70 | 3.80 | 1,546,515 | 3.80 |
| 11/22/2024 | 3.84 | 3.90 | 3.69 | 3.73 | 1,824,534 | 3.73 |
| 11/21/2024 | 3.77 | 3.88 | 3.76 | 3.84 | 683,315 | 3.84 |
| 11/20/2024 | 3.92 | 3.92 | 3.68 | 3.80 | 1,472,094 | 3.80 |
| 11/19/2024 | 3.96 | 4.00 | 3.64 | 3.76 | 1,913,604 | 3.76 |
| 11/18/2024 | 4.18 | 4.18 | 3.98 | 3.99 | 1,385,976 | 3.99 |
| 11/15/2024 | 4.30 | 4.30 | 4.13 | 4.17 | 1,214,061 | 4.17 |
| 11/14/2024 | 4.29 | 4.37 | 4.17 | 4.31 | 1,485,434 | 4.31 |
| 11/13/2024 | 4.12 | 4.29 | 4.00 | 4.24 | 1,990,303 | 4.24 |
| 11/12/2024 | 3.47 | 4.26 | 3.42 | 4.13 | 6,600,829 | 4.13 |
| 11/11/2024 | 3.75 | 3.90 | 3.36 | 3.45 | 6,270,738 | 3.45 |
| 11/08/2024 | 4.25 | 4.34 | 3.48 | 3.70 | 13,145,845 | 3.70 |
| 11/07/2024 | 5.80 | 5.90 | 5.73 | 5.78 | 1,388,417 | 5.78 |
| 11/06/2024 | 5.95 | 5.97 | 5.67 | 5.81 | 1,592,401 | 5.81 |
| 11/05/2024 | 5.80 | 5.90 | 5.73 | 5.84 | 654,544 | 5.84 |
| 11/04/2024 | 5.80 | 5.85 | 5.64 | 5.81 | 1,024,358 | 5.81 |
| 11/01/2024 | 5.88 | 5.92 | 5.59 | 5.80 | 1,673,258 | 5.80 |
| 10/31/2024 | 5.92 | 5.94 | 5.83 | 5.90 | 1,417,582 | 5.90 |
| 10/30/2024 | 5.91 | 5.95 | 5.88 | 5.92 | 1,131,773 | 5.92 |
| 10/29/2024 | 5.90 | 5.96 | 5.85 | 5.91 | 1,125,270 | 5.91 |
| 10/28/2024 | 6.00 | 6.09 | 5.85 | 5.90 | 8,946,599 | 5.90 |
| 10/25/2024 | 5.34 | 5.34 | 4.68 | 4.70 | 2,826,594 | 4.70 |
| 10/24/2024 | 5.29 | 5.36 | 5.25 | 5.30 | 779,302 | 5.30 |
| 10/23/2024 | 5.28 | 5.33 | 5.22 | 5.29 | 864,811 | 5.29 |
| 10/22/2024 | 5.29 | 5.30 | 5.25 | 5.29 | 487,115 | 5.29 |
| 10/21/2024 | 5.28 | 5.32 | 5.26 | 5.28 | 895,013 | 5.28 |
| 10/18/2024 | 5.15 | 5.43 | 5.10 | 5.29 | 1,887,092 | 5.29 |
| 10/17/2024 | 5.24 | 5.28 | 5.13 | 5.18 | 1,173,406 | 5.18 |
| 10/16/2024 | 5.21 | 5.34 | 5.19 | 5.28 | 832,302 | 5.28 |
| 10/15/2024 | 5.12 | 5.28 | 5.08 | 5.20 | 1,218,045 | 5.20 |
| 10/14/2024 | 5.29 | 5.30 | 5.08 | 5.14 | 1,123,973 | 5.14 |
| 10/11/2024 | 5.25 | 5.30 | 5.15 | 5.28 | 1,048,243 | 5.28 |
| 10/10/2024 | 5.23 | 5.29 | 5.13 | 5.26 | 631,871 | 5.26 |
| 10/09/2024 | 5.23 | 5.29 | 5.13 | 5.24 | 864,273 | 5.24 |
| 10/08/2024 | 5.35 | 5.36 | 5.22 | 5.22 | 1,250,472 | 5.22 |
| 10/07/2024 | 5.22 | 5.41 | 5.19 | 5.33 | 1,344,600 | 5.33 |
| 10/04/2024 | 5.25 | 5.34 | 5.01 | 5.22 | 2,556,544 | 5.22 |
| 10/03/2024 | 5.20 | 5.28 | 5.18 | 5.26 | 2,820,287 | 5.26 |
| 10/02/2024 | 5.18 | 5.26 | 5.17 | 5.19 | 1,230,410 | 5.19 |
| 10/01/2024 | 5.23 | 5.32 | 5.16 | 5.20 | 1,197,822 | 5.20 |
| 9/30/2024 | 5.30 | 5.44 | 5.19 | 5.19 | 1,952,739 | 5.19 |
| 9/27/2024 | 5.45 | 5.51 | 5.30 | 5.36 | 1,030,258 | 5.36 |
| 9/26/2024 | 5.35 | 5.50 | 5.25 | 5.39 | 1,585,000 | 5.39 |
| 9/25/2024 | 5.51 | 5.52 | 5.29 | 5.30 | 1,574,670 | 5.30 |
| 9/24/2024 | 5.23 | 5.65 | 5.23 | 5.50 | 1,268,863 | 5.50 |
| 9/23/2024 | 5.14 | 5.44 | 5.11 | 5.37 | 8,809,007 | 5.37 |
| 9/20/2024 | 5.85 | 5.91 | 5.74 | 5.81 | 5,475,959 | 5.81 |
| 9/19/2024 | 6.03 | 6.05 | 5.72 | 5.85 | 5,399,901 | 5.85 |
| 9/18/2024 | 5.95 | 6.30 | 5.89 | 5.99 | 5,500,095 | 5.99 |
| 9/17/2024 | 6.02 | 6.26 | 5.84 | 5.96 | 5,536,534 | 5.96 |
| 9/16/2024 | 6.54 | 6.57 | 5.44 | 5.97 | 20,812,788 | 5.97 |
| 9/13/2024 | 6.58 | 6.59 | 6.54 | 6.55 | 10,524,331 | 6.55 |